OnkoGenetiks® Hereditary Cancer Panel
Definition
Multi-gene hereditary cancer panels provide cost-effective screening in situations where a single family phenotype may be explained by more than one gene; they can include 14 to 30 cancer susceptibility genes. NCCN offers management recommendations for genes such as CDH1, MSH2, MLH1, MSH6, PMS2, PTEN, STK11 and TP53.
Method
Next Generation Sequencing
Accepted sample types
Blood (EDTA)
Description
275 gene regions associated with familial cancers are analyzed.
Inheritance
This is a germline (hereditary) multi-gene analysis; it forms the basis for cascade testing in family members and risk-reducing follow-up decisions.